FCC Approves Nexstar Tegna Merger, Local TV Giant Emerges
The FCC has approved the Nexstar-Tegna deal, creating a national local television powerhouse with 265 stations across...
Which Retirement Account Is Right For Me At 30
Choosing the right retirement account at 30 can be challenging. Learn about the different options available to make the best choice for your future.
22,749 articlesCybersecurity Stocks Generative Era: 3 Top AI Security Picks
As GenAI reshapes software, security becomes non-negotiable. Here are three cybersecurity stocks generative AI advoca...
Iran Making World Little as Oil Surges, Sugar Risk
Oil prices near $100 a barrel collide with Brazil's sugar-and-ethanol balance, threatening tighter sugar supplies jus...
This $19.8 Million Commvault Bet: Investor Insights
As Commvault shares dive, a fresh $19.8 million stake signals confidence from a hedge fund with a plan. Here's how to...
Deadliest Weapons Built Urban Shape Defense Stocks Rally
Investors are shifting bets toward defense names as urban warfare tech dominates modernization plans. This piece exam...
Apple Set to Hit $303 Target Over Next 12 Months Ahead
Apple faces a window of opportunity as upbeat quarterly results and expanding services/supporting growth drivers push...
Swift Blockchain Pivot Puts XRP in Cross-Border Spotlight
SWIFT is moving its blockchain-based cross-border settlement from pilot to production-scale, with a mid-2026 MVP and ...
Accelerant Sells $638K Stock: What That Means for Investors
When a chief financial officer sells a sizable chunk of stock, it draws attention. This article breaks down the impli...
Better, Coinbase Launch Crypto-Backed Conforming Mortgage
Better Home & Finance and Coinbase rolled out a crypto-backed conforming mortgage option that lets qualified borrower...
Software Stocks Proved Resilient Amid Tech Selloff
On a downbeat tech day, software stocks proved resilient as cloud demand and subscription revenue buoyed leaders like...
Corcept Therapeutics Zoomed Nearly: What Fueled the Week
This week brought a notable rise for Corcept Therapeutics as investors reacted to a major catalyst. Learn what drove ...
Argus Upgrades Palantir to Buy After Sell-Off: Is $190 Floor?
Palantir surged into focus after blowout Q1 results and a fresh Buy rating from Argus with a $190 target, raising que...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status